<?xml version="1.0" encoding="UTF-8"?>
<p xmlns="http://www.w3.org/1999/xhtml">
 <p> ( A) Experimental strategy of the model with days of exposure to LPS and proposed therapy with essential oil; ( B) animals weight during treatment; ( C) macroscopical view of mice colon (i) and colon lenght (ii) of each group; ( D) microscopical analysis of colon tissues of TA-1 (LD) group (a), TA-1 (HD) group (b), 5-Fu group (c), LPS group (d, e and f), LPS + TA-1 group (g, h), and LPS + 5-Fu group (i). ( E) macroscopical view (i) and the histological overview (ii) of lung and spleen of different groups. TA-1: Teucrium alopecurus essential oil; LD: low dose; HD: high dose; 5-Fu: 5-Fluorouracil; LPS: Lipopolysaccharides. </p>
 <p/>
 <p>Figure 8</p>
</p>
